T1	PROC 1 15	Estudio piloto
#1	AnnotatorNotes T1	C0031928; Pilot Projects; Research Activity
T2	DISO 112 144	diarrea causada por C. difficile
#2	AnnotatorNotes T2	C0235952; Clostridium difficile diarrhea; Disease or Syndrome
T3	DISO 149 193	infección de colon por Clostridium difficile
#3	AnnotatorNotes T3	C0494025; Intestinal infection due to clostridium difficile; Disease or Syndrome
T4	DISO 207 231	colitis pseudomembranosa
#4	AnnotatorNotes T4	C0238106; Clostridium difficile colitis; Disease or Syndrome | C1257843; pseudomembranous colitis; Disease or Syndrome
T5	DISO 240 252	complicación
#5	AnnotatorNotes T5	C0009566; Complication; Pathologic Function
T6	PROC 270 278	terapias
#6	AnnotatorNotes T6	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T7	PROC 53 88	aporte suplementario de probióticos
#7	AnnotatorNotes T7	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T8	PROC 410 418	prevenir
#8	AnnotatorNotes T8	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T9	DISO 439 465	infección por C. difficile
#9	AnnotatorNotes T9	C0343386; Clostridium difficile infection; Disease or Syndrome
T10	PROC 473 525	estudio de doble ciego con control mediante placebos
#10	AnnotatorNotes T10	C0013072; Double-Blind Method; Research Activity + C0599724; placebo controlled study; Research Activity · Intellectual Product
T11	PROC 717 735	escogieron al azar
#11	AnnotatorNotes T11	C0034656; Randomization; Research Activity
T12	PROC 999 1012	muestra fecal
#12	AnnotatorNotes T12	C0455051; Collection of stool specimen; Health Care Activity
T13	PROC 590 600	prevención
#13	AnnotatorNotes T13	C0199176; Prophylactic treatment; Therapeutic or Preventive Procedure
T14	PROC 687 694	terapia
#14	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	PROC 775 782	terapia
#15	AnnotatorNotes T15	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T16	PROC 915 922	placebo
#16	AnnotatorNotes T16	C0032042; Placebos; Therapeutic or Preventive Procedure
T17	PROC 932 952	ingreso hospitalario
#17	AnnotatorNotes T17	C0184666; Hospital admission; Health Care Activity
T18	ANAT 974 984	intestinal
#18	AnnotatorNotes T18	C0021853; Intestines; Body Part, Organ, or Organ Component | C1318303; Entire intestine; Body Part, Organ, or Organ Component
T19	ANAT 1007 1012	fecal
#19	AnnotatorNotes T19	C0015733; Feces; Body Substance
T20	PROC 1033 1040	placebo
#20	AnnotatorNotes T20	C0032042; Placebos; Therapeutic or Preventive Procedure
T21	PROC 1085 1096	tratamiento
#21	AnnotatorNotes T21	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T22	ANAT 1148 1153	heces
#22	AnnotatorNotes T22	C0015733; Feces; Body Substance
T23	DISO 1177 1184	diarrea
#23	AnnotatorNotes T23	C0011991; Diarrhea; Sign or Symptom
T24	PROC 1196 1211	hospitalización
#24	AnnotatorNotes T24	C0019993; Hospitalization; Health Care Activity
T25	PROC 1222 1233	alta médica
#25	AnnotatorNotes T25	C0030685; Patient Discharge; Health Care Activity | C0586003; Discharge from hospital; Health Care Activity
T26	PROC 1295 1303	tratados
#26	AnnotatorNotes T26	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T27	DISO 1401 1408	diarrea
#27	AnnotatorNotes T27	C0011991; Diarrhea; Sign or Symptom
T28	CHEM 1460 1490	toxina asociada a C. difficile
#28	AnnotatorNotes T28	C0314765; Clostridium difficile toxin; Amino Acid, Peptide, or Protein · Biologically Active Substance · Hazardous or Poisonous Substance
T29	CHEM 699 711	antibióticos
#29	AnnotatorNotes T29	C0003232; Antibiotics; Antibiotic
T30	PROC 1503 1526	tratado con probióticos
#30	AnnotatorNotes T30	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T32	DISO 1691 1698	diarrea
#31	AnnotatorNotes T32	C0011991; Diarrhea; Sign or Symptom
T33	CHEM 1774 1780	toxina
#32	AnnotatorNotes T33	C0040549; Toxin; Biologically Active Substance · Hazardous or Poisonous Substance
T34	PROC 820 834	aleatoriamente
#33	AnnotatorNotes T34	C0034656; Randomization; Research Activity
T35	ANAT 162 167	colon
#34	AnnotatorNotes T35	C0009368; Colon structure; Body Part, Organ, or Organ Component | C1281569; Entire colon; Body Part, Organ, or Organ Component
T36	PROC 1137 1153	muestra de heces
#35	AnnotatorNotes T36	C0455051; Collection of stool specimen; Health Care Activity
T37	PROC 554 583	administración de probióticos
#36	AnnotatorNotes T37	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T38	DISO 604 635	diarrea asociada a C. difficile
#37	AnnotatorNotes T38	C0235952; Clostridium difficile diarrhea; Disease or Syndrome
T39	CHEM 283 295	antibióticos
#38	AnnotatorNotes T39	C0003232; Antibiotics; Antibiotic
T40	PHYS 966 984	régimen intestinal
T41	CHEM 1101 1113	antibióticos
#39	AnnotatorNotes T41	C0003232; Antibiotics; Antibiotic
T42	CHEM 1308 1320	antibióticos
#40	AnnotatorNotes T42	C0003232; Antibiotics; Antibiotic
T43	CHEM 1354 1366	antibióticos
#41	AnnotatorNotes T43	C0003232; Antibiotics; Antibiotic
T44	CHEM 787 799	antibióticos
#42	AnnotatorNotes T44	C0003232; Antibiotics; Antibiotic
T45	PROC 1725 1749	tratados con probióticos
#43	AnnotatorNotes T45	C2242626; Probiotic therapy; Therapeutic or Preventive Procedure
T46	PROC 1818 1837	tratado con placebo
#44	AnnotatorNotes T46	C3897898; Placebo Administration; Therapeutic or Preventive Procedure
T47	DISO 637 641	CDAD
#45	AnnotatorNotes T47	C0235952; Clostridium difficile diarrhea; Disease or Syndrome
T48	PROC 1433 1441	muestras
#46	AnnotatorNotes T48	C0455051; Collection of stool specimen; Health Care Activity
T49	ANAT 1628 1636	muestras
#47	AnnotatorNotes T49	C2347026; Biospecimen; Body Substance
T50	PROC 1614 1636	se analizaron muestras
#48	AnnotatorNotes T50	C1303103; Sample analysis; Laboratory Procedure
T51	LIVB 19 40	Clostridium difficile
#49	AnnotatorNotes T51	C0079134; Clostridium difficile; Bacterium
T52	LIVB 77 88	probióticos
#50	AnnotatorNotes T52	C0525033; Probiotics; Bacterium
T53	LIVB 172 193	Clostridium difficile
#51	AnnotatorNotes T53	C0079134; Clostridium difficile; Bacterium
T54	LIVB 314 342	pacientes de la tercera edad
#52	AnnotatorNotes T54	C0030705; Patients; Patient or Disabled Group + C0001792; Elderly (population group); Population Group
T55	Age 330 342	tercera edad
T57	LIVB 367 388	bacterias probióticas
#53	AnnotatorNotes T57	C0525033; Probiotics; Bacterium
T59	Spec_cue 402 409	podrían
T60	LIVB 572 583	probióticos
#54	AnnotatorNotes T60	C0525033; Probiotics; Bacterium
T61	LIVB 646 674	pacientes de la tercera edad
#55	AnnotatorNotes T61	C0030705; Patients; Patient or Disabled Group + C0001792; Elderly (population group); Population Group
T62	Age 662 674	tercera edad
T63	LIVB 740 749	pacientes
#56	AnnotatorNotes T63	C0030705; Patients; Patient or Disabled Group
T64	Duration 843 850	20 días
T65	LIVB 854 864	probiótico
#57	AnnotatorNotes T65	C0525033; Probiotics; Bacterium
T66	LIVB 878 891	Lactobacillus
#58	AnnotatorNotes T66	C0022938; Lactobacillus; Bacterium
T67	LIVB 894 909	Bifidobacterium
#59	AnnotatorNotes T67	C0005380; Bifidobacterium; Bacterium
T68	LIVB 1017 1027	probiótico
#60	AnnotatorNotes T68	C0525033; Probiotics; Bacterium
T69	Duration 1063 1080	las 72 h primeras
T70	LIVB 1243 1252	pacientes
#61	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	LIVB 1323 1334	probióticos
#62	AnnotatorNotes T71	C0525033; Probiotics; Bacterium
T72	LIVB 1378 1387	pacientes
#63	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T73	LIVB 1515 1526	probióticos
#64	AnnotatorNotes T73	C0525033; Probiotics; Bacterium
T74	LIVB 1572 1585	grupo control
#65	AnnotatorNotes T74	C0009932; Control Groups; Group
T75	LIVB 1650 1659	pacientes
#66	AnnotatorNotes T75	C0030705; Patients; Patient or Disabled Group
T77	LIVB 1715 1724	pacientes
#67	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	LIVB 1738 1749	probióticos
#68	AnnotatorNotes T78	C0525033; Probiotics; Bacterium
T79	LIVB 132 144	C. difficile
#69	AnnotatorNotes T79	C0079134; Clostridium difficile; Bacterium
T56	LIVB 453 465	C. difficile
#70	AnnotatorNotes T56	C0079134; Clostridium difficile; Bacterium
T58	LIVB 623 635	C. difficile
#71	AnnotatorNotes T58	C0079134; Clostridium difficile; Bacterium
T76	Spec_cue 350 358	sugerido
T31	PROC 1586 1605	tratado con placebo
#72	AnnotatorNotes T31	C3897898; Placebo Administration; Therapeutic or Preventive Procedure
A1	Population_data T54 Age
A2	Assertion T8 Speculated
A3	Population_data T61 Age
A4	Assertion T57 Speculated
T80	Neg_cue 389 391	no
T81	Quantifier_or_Qualifier 392 401	patógenas
A5	Assertion T81 Negated
R1	Has_Quantifier_or_Qualifier Arg1:T57 Arg2:T81	
R2	Negation Arg1:T80 Arg2:T81	
R3	Used_for Arg1:T52 Arg2:T7	
R4	Causes Arg1:T79 Arg2:T2	
R5	Location_of Arg1:T18 Arg2:T40	
R6	Location_of Arg1:T35 Arg2:T3	
R7	Causes Arg1:T53 Arg2:T3	
R8	Causes Arg1:T3 Arg2:T4	
R9	Used_for Arg1:T39 Arg2:T6	
R11	Overlap Arg1:T3 Arg2:T6	
R12	Has_Age Arg1:T54 Arg2:T55	
R13	Experiences Arg1:T54 Arg2:T6	
R14	Experiences Arg1:T54 Arg2:T5	
R15	Experiences Arg1:T54 Arg2:T4	
R16	Experiences Arg1:T54 Arg2:T3	
R17	Speculation Arg1:T76 Arg2:T57	
R18	Speculation Arg1:T59 Arg2:T8	
R19	Experiences Arg1:T56 Arg2:T9	
R20	Before Arg1:T8 Arg2:T9	
R21	Used_for Arg1:T60 Arg2:T37	
R22	Before Arg1:T13 Arg2:T38	
R25	Causes Arg1:T58 Arg2:T38	
R26	Causes Arg1:T58 Arg2:T47	
R27	Has_Age Arg1:T61 Arg2:T62	
R28	Experiences Arg1:T61 Arg2:T47	
R29	Experiences Arg1:T61 Arg2:T38	
R30	Experiences Arg1:T61 Arg2:T37	
R31	Experiences Arg1:T61 Arg2:T14	
R32	Used_for Arg1:T29 Arg2:T14	
R35	Before Arg1:T14 Arg2:T37	
T82	Quantifier_or_Qualifier 750 762	consecutivos
#73	AnnotatorNotes T82	C1707491; Consecutive; Qualitative Concept
R36	Has_Quantifier_or_Qualifier Arg1:T63 Arg2:T82	
R37	Used_for Arg1:T44 Arg2:T15	
R38	Before Arg1:T11 Arg2:T65	
R39	Before Arg1:T11 Arg2:T66	
R40	Before Arg1:T11 Arg2:T67	
R41	Before Arg1:T11 Arg2:T16	
R42	Has_Duration_or_Interval Arg1:T65 Arg2:T64	
R43	Has_Duration_or_Interval Arg1:T66 Arg2:T64	
R44	Has_Duration_or_Interval Arg1:T67 Arg2:T64	
R45	Has_Duration_or_Interval Arg1:T16 Arg2:T64	
R46	Experiences Arg1:T63 Arg2:T15	
R47	Before Arg1:T34 Arg2:T65	
R48	Before Arg1:T34 Arg2:T66	
R49	Before Arg1:T34 Arg2:T67	
R50	Before Arg1:T34 Arg2:T16	
R51	Before Arg1:T15 Arg2:T11	
R52	Before Arg1:T15 Arg2:T34	
R53	Experiences Arg1:T63 Arg2:T16	
R54	Before Arg1:T17 Arg2:T84	
R55	Before Arg1:T17 Arg2:T12	
R56	Has_Duration_or_Interval Arg1:T68 Arg2:T69	
R57	Has_Duration_or_Interval Arg1:T20 Arg2:T69	
R58	Used_for Arg1:T41 Arg2:T21	
R59	Overlap Arg1:T68 Arg2:T21	
R60	Overlap Arg1:T20 Arg2:T21	
T83	Quantifier_or_Qualifier 1129 1136	segunda
R61	Overlap Arg1:T83 Arg2:T36	
R62	Before Arg1:T68 Arg2:T36	
R63	Before Arg1:T20 Arg2:T36	
R65	Overlap Arg1:T23 Arg2:T24	
R66	After Arg1:T23 Arg2:T25	
R67	Before Arg1:T68 Arg2:T23	
R68	Before Arg1:T68 Arg2:T24	
R69	Before Arg1:T68 Arg2:T25	
R70	Before Arg1:T21 Arg2:T36	
R71	Before Arg1:T21 Arg2:T23	
R72	Before Arg1:T21 Arg2:T24	
R73	Before Arg1:T21 Arg2:T25	
#74	AnnotatorNotes T40	C0011135; Defecation; Organism Function
T84	PROC 957 984	anotó su régimen intestinal
#75	AnnotatorNotes T84	C0513008; Monitor bowel habits; Therapeutic or Preventive Procedure
T85	Observation 1268 1290	completaron el estudio
#76	AnnotatorNotes T85	C2732579; Completion of clinical trial; Finding
R75	Experiences Arg1:T70 Arg2:T26	
R76	Used_for Arg1:T42 Arg2:T26	
T86	Quantifier_or_Qualifier 1340 1349	solamente
R78	Has_Quantifier_or_Qualifier Arg1:T43 Arg2:T86	
R79	Experiences Arg1:T70 Arg2:T43	
R80	Experiences Arg1:T72 Arg2:T27	
R81	Experiences Arg1:T72 Arg2:T48	
T87	Result_or_Value 1442 1451	positivas
#77	AnnotatorNotes T87	C1446409; Positive; Finding
R83	Has_Result_or_Value Arg1:T48 Arg2:T87	
R84	Causes Arg1:T28 Arg2:T87	
R85	Used_for Arg1:T73 Arg2:T30	
R86	Experiences Arg1:T72 Arg2:T30	
R87	Experiences Arg1:T74 Arg2:T31	
R89	Experiences Arg1:T74 Arg2:T48	
R90	Experiences Arg1:T74 Arg2:T27	
R91	Experiences Arg1:T75 Arg2:T32	
R92	Experiences Arg1:T77 Arg2:T45	
R93	Used_for Arg1:T78 Arg2:T45	
T88	Result_or_Value 1757 1765	positivo
#78	AnnotatorNotes T88	C1446409; Positive; Finding
R95	Causes Arg1:T33 Arg2:T88	
R96	Experiences Arg1:T75 Arg2:T45	
R98	Experiences Arg1:T77 Arg2:T46	
R99	Experiences Arg1:T75 Arg2:T46	
R100	Before Arg1:T45 Arg2:T50	
R101	Before Arg1:T46 Arg2:T50	
R102	Before Arg1:T30 Arg2:T48	
R105	Before Arg1:T31 Arg2:T48	
R106	Causes Arg1:T51 Arg2:T2	
T89	Observation 42 48	efecto
#79	AnnotatorNotes T89	C0235735; Unexpected therapeutic effect; Finding (?)
R107	Causes Arg1:T7 Arg2:T89	
R108	Overlap Arg1:T15 Arg2:T65	
R109	Overlap Arg1:T15 Arg2:T66	
R110	Overlap Arg1:T15 Arg2:T67	
R111	Overlap Arg1:T15 Arg2:T16	
R112	Combined_with Arg1:T42 Arg2:T71	
R77	Used_for Arg1:T57 Arg2:T8	
R23	Used_for Arg1:T60 Arg2:T13	
#80	AnnotatorNotes T83	C0205436; second (number); Quantitative Concept
R10	Overlap Arg1:T36 Arg2:T23	
R24	Before Arg1:T30 Arg2:T27	
R33	Before Arg1:T45 Arg2:T32	
R34	Before Arg1:T46 Arg2:T32	
#81	AnnotatorNotes T86	C0205171; Singular; Quantitative Concept
A6	Experiencer T75 Patient
A7	Experiencer T74 Patient
A8	Experiencer T77 Patient
A9	Experiencer T54 Patient
A10	Experiencer T61 Patient
A11	Experiencer T63 Patient
A12	Experiencer T70 Patient
A13	Experiencer T72 Patient
